Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 61,800 | 78,477 | 64,260 | 64,027 | 49,614 |
| Operating Income | -61,800 | -78,477 | -64,260 | -64,027 | -49,614 |
| Other Income | 3,592 | 4,529 | 3,837 | 1,187 | 1,947 |
| Pre-tax Income | -58,208 | -73,948 | -60,423 | -62,840 | -47,667 |
| Income Tax | 454 | -11 | -991 | 387 | 261 |
| Net Income Continuous | -58,662 | -73,937 | -59,432 | -63,227 | -47,928 |
| Net Income | $-58,662 | $-73,937 | $-59,432 | $-63,227 | $-47,928 |
| EPS Basic Total Ops | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 |
| EPS Basic Continuous Ops | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 |
| EPS Diluted Total Ops | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 |
| EPS Diluted Continuous Ops | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 |
| EBITDA(a) | $-61,800 | $-78,477 | $-64,206 | $-63,978 | $-49,568 |